Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
6.93
+0.30 (4.52%)
At close: Oct 20, 2025, 4:00 PM EDT
6.90
-0.03 (-0.42%)
After-hours: Oct 20, 2025, 7:50 PM EDT

BioCryst Pharmaceuticals Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
531.59M483.04M437.66M404.36M373.72M346.44M325.99M305.84M
Orladeyo Growth
42.24%39.43%34.26%32.21%30.61%28.15%29.55%-
Other
25.92M20.45M13.05M8.22M8.51M8.95M5.42M11.72M
Other Growth
204.45%128.43%140.72%-29.82%-58.49%-53.71%-71.75%-

Revenue by Type

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
551.63M497.18M442.67M404.06M373.29M345.80M324.70M312.02M
Product Growth
47.78%43.78%36.33%29.50%23.63%20.77%21.29%-
Collaborative and Other
5.88M6.30M8.04M8.52M8.95M9.59M6.72M5.54M
Collaborative and Other Growth
-34.31%-34.31%19.77%53.86%90.65%186.19%115.46%-

Revenue by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
470.58M426.15M385.96M358.41M330.57M307.48M288.36M272.55M
United States Growth
42.36%38.60%33.85%31.50%28.43%26.39%27.39%-
Outside of US
61.00M56.88M51.70M45.94M43.15M38.97M37.63M33.29M
Outside of US Growth
41.37%45.98%37.39%38.00%50.14%43.94%48.88%-
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.